Skip to main content
Log in

ASO Visual Abstract: Prognostic Value of Myosteatosis and Creatinine-to-Cystatin-C Ratio in Patients with Pancreatic Cancer Who Underwent Radical Surgery

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Data availability

The data presented in this study are available on request from the corresponding author (X.J.).

Funding

This research was funded by the National Natural Science Foundation of Shandong Province, Grant No. ZR202103040311.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xue Jing MD.

Ethics declarations

Disclosure

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Ethical statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Clinical Trials Committee (NCT05584852) and the Ethics Committee of the Affiliated Hospital of Qingdao University (QYFYWZLL27348).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bi, S., Jiang, Y., Guan, G. et al. ASO Visual Abstract: Prognostic Value of Myosteatosis and Creatinine-to-Cystatin-C Ratio in Patients with Pancreatic Cancer Who Underwent Radical Surgery. Ann Surg Oncol 31, 2981–2982 (2024). https://doi.org/10.1245/s10434-024-15133-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-024-15133-y

Navigation